                                 CODE OF VIRGINIA

DISPENSING CANNABIS PRODUCTS; REPORT (§ 4.1-1603)

A. A pharmaceutical processor or cannabis dispensing facility shall dispense or
deliver cannabis products only in person to (i) a patient who is a Virginia
resident or temporarily resides in Virginia and has been issued a valid written
certification; (ii) such patient&#8217;s registered agent; or (iii) if such
patient is a minor or a vulnerable adult as defined in &#xA7; 18.2-369, such
patient&#8217;s parent or legal guardian who is a Virginia resident or
temporarily resides in Virginia. A companion may accompany a patient into a
pharmaceutical processor&#8217;s dispensing area or cannabis dispensing
facility. Prior to the initial dispensing of cannabis products pursuant to each
written certification, a pharmacist or pharmacy technician employed by the
pharmaceutical processor or cannabis dispensing facility shall make and
maintain, on site or remotely by electronic means, for two years a paper or
electronic copy of the written certification that provides an exact image of the
document that is clearly legible; shall view, in person or by audiovisual means,
a current photo identification of the patient, registered agent, parent, or
legal guardian; and shall verify current board registration of the corresponding
registered agent if applicable. Thereafter, an initial dispensing may be
delivered to the patient, registered agent, parent, legal guardian, or
designated caregiver facility. Prior to any subsequent dispensing of cannabis
products pursuant to each written certification, an employee or delivery agent
shall view a current photo identification of the patient, registered agent,
parent, or legal guardian and the current board registration issued to the
registered agent if applicable. No pharmaceutical processor or cannabis
dispensing facility shall dispense more than a 90-day supply, as determined by
the dispensing pharmacist or certifying practitioner, for any patient during any
90-day period. A pharmaceutical processor or cannabis dispensing facility may
dispense less than a 90-day supply of a cannabis product for any patient during
any 90-day period; however, a pharmaceutical processor or cannabis dispensing
facility may dispense more than one cannabis product to a patient at one time.
No more than four ounces of botanical cannabis shall be dispensed for each
30-day period for which botanical cannabis is dispensed. In determining the
appropriate amount of a cannabis product to be dispensed to a patient, a
pharmaceutical processor or cannabis dispensing facility shall consider all
cannabis products dispensed to the patient and adjust the amount dispensed
accordingly.

B. A pharmaceutical processor or cannabis dispensing facility shall dispense
only cannabis products produced on the premises of a pharmaceutical processor
permitted by the Board or cannabis products that have been formulated with
extracts from industrial hemp acquired by a pharmaceutical processor from a
registered industrial hemp handler or processor pursuant to &#xA7; 4.1-1602. A
pharmaceutical processor may begin cultivation upon being issued a permit by the
Board.

C. The Board shall report annually by December 1 to the Chairmen of the House
Committee on General Laws and the Senate Committee on Rehabilitation and Social
Services on the operation of pharmaceutical processors and cannabis dispensing
facilities issued a permit by the Board.

D. The concentration of total tetrahydrocannabinol in any cannabis product on
site may be up to 15 percent greater than or less than the level of total
tetrahydrocannabinol listed in the approved cannabis product registration. A
pharmaceutical processor and cannabis dispensing facility shall ensure that such
concentration in any cannabis product on site is within such range. A
pharmaceutical processor producing cannabis products shall establish a stability
testing schedule of cannabis products that have an expiration date of longer
than 12 months.

HISTORY: 2023, cc. 740, 744, 760, 773, 780, 794; 2024, c. 732.